Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid, highly selective NaV1.8 pain signal inhibitor, suzetrigine, for the treatment of adults with moderate ...
Learn more Recovering from back pain is a delicate process. Rest is of the utmost importance, but your mattress could also be contributing to your discomfort. Sleeping on a supportive mattress is ...
However, it is a problem and a challenge that healthcare professionals are not always able to determine whether children are in pain. "This involves developing better rating scales or ...
FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...
Research on pain in preterm infants shows frequent painful procedures and inadequate pain management, emphasizing the need for better assessment strategies.